PL370529A1 - Zastosowanie pochodnych 2-okso-1-pirolidyny do wytwarzania leku - Google Patents
Zastosowanie pochodnych 2-okso-1-pirolidyny do wytwarzania lekuInfo
- Publication number
- PL370529A1 PL370529A1 PL02370529A PL37052902A PL370529A1 PL 370529 A1 PL370529 A1 PL 370529A1 PL 02370529 A PL02370529 A PL 02370529A PL 37052902 A PL37052902 A PL 37052902A PL 370529 A1 PL370529 A1 PL 370529A1
- Authority
- PL
- Poland
- Prior art keywords
- oxo
- drug
- preparation
- pyrrolidine derivatives
- derivatives
- Prior art date
Links
- 239000003814 drug Substances 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 abstract 2
- WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 abstract 1
- WTDRDQBEARUVNC-UHFFFAOYSA-N L-Dopa Natural products OC(=O)C(N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-UHFFFAOYSA-N 0.000 abstract 1
- 208000018737 Parkinson disease Diseases 0.000 abstract 1
- 230000001684 chronic effect Effects 0.000 abstract 1
- 229960003638 dopamine Drugs 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 238000009256 replacement therapy Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychology (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP01123976 | 2001-10-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL370529A1 true PL370529A1 (pl) | 2005-05-30 |
Family
ID=8178883
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL02370529A PL370529A1 (pl) | 2001-10-08 | 2002-10-07 | Zastosowanie pochodnych 2-okso-1-pirolidyny do wytwarzania leku |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US20040242671A1 (pl) |
| EP (1) | EP1435943B1 (pl) |
| JP (1) | JP4351909B2 (pl) |
| AT (1) | ATE353645T1 (pl) |
| AU (1) | AU2002340971B2 (pl) |
| CA (1) | CA2461961A1 (pl) |
| DE (1) | DE60218193T2 (pl) |
| ES (1) | ES2281545T3 (pl) |
| HU (1) | HUP0401667A2 (pl) |
| MX (1) | MXPA04002714A (pl) |
| PL (1) | PL370529A1 (pl) |
| WO (1) | WO2003030899A2 (pl) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004071449A2 (en) | 2003-02-12 | 2004-08-26 | Bristol-Myers Squibb Company | Lactams as modulators of chemokine receptor activity |
| WO2008095221A1 (en) | 2007-02-07 | 2008-08-14 | Gosforth Centre (Holdings) Pty Ltd | Treatment of adhd |
| WO2010002869A1 (en) * | 2008-07-01 | 2010-01-07 | Concert Pharmaceuticals, Inc. | 2-oxo-1-pyrrolidine derivatives |
| MX2011001384A (es) | 2008-08-06 | 2011-09-27 | Gosforth Ct Holdings Pty Ltd | Composiciones y metodos para tratar trastornos psiquiatricos. |
| WO2012027825A1 (en) * | 2010-08-31 | 2012-03-08 | Mcmaster University | Method of treating dopamine-related neuropsychiatric disorders |
| AU2014357342B2 (en) | 2013-12-03 | 2019-01-17 | Fmc Corporation | Pyrrolidinones as herbicides |
| US11589583B2 (en) | 2013-12-03 | 2023-02-28 | Fmc Corporation | Pyrrolidinones herbicides |
| UA125012C2 (uk) | 2014-07-02 | 2021-12-29 | ЕфЕмСі КОРПОРЕЙШН | Піперидинонові гербіциди |
| BR112017009701B1 (pt) | 2014-12-08 | 2021-09-08 | Fmc Corporation | Composto e métodos de preparação de compostos |
| WO2016164201A1 (en) | 2015-04-10 | 2016-10-13 | E I Du Pont De Nemours And Company | Substituted cyclic amides as herbicides |
| BR112017020094B1 (pt) | 2015-04-27 | 2022-01-11 | Fmc Corporation | Composto, composições herbicidas, mistura de herbicida e método para controlar o crescimento de vegetação indesejada |
| RU2750293C2 (ru) | 2015-05-12 | 2021-06-25 | ЭфЭмСи Корпорейшн | Арилзамещенные бициклические соединения в качестве гербицидов |
| CN107690426B (zh) | 2015-05-29 | 2021-07-06 | Fmc公司 | 作为除草剂的取代的环酰胺 |
| RU2017142979A (ru) | 2015-06-02 | 2019-07-15 | ЭфЭмСи Корпорейшн | Замещенные циклические амиды и их применение в качестве гербицидов |
| RU2720994C2 (ru) | 2015-07-31 | 2020-05-15 | Е.И.Дюпон Де Немур Энд Компани | Новые соединения циклического n-карбоксамида, применяемые в качестве гербицидов |
| ES2958741T3 (es) | 2016-12-21 | 2024-02-14 | Fmc Corp | Herbicidas de nitrona |
| UA126576C2 (uk) | 2017-03-21 | 2022-11-02 | ЕфЕмСі КОРПОРЕЙШН | Гербіцидна суміш, композиція та спосіб |
| CN110691516B (zh) | 2017-03-21 | 2022-10-28 | Fmc公司 | 吡咯烷酮及其制备方法 |
| AR111967A1 (es) | 2017-05-30 | 2019-09-04 | Fmc Corp | Amidas herbicidas |
| AR111839A1 (es) | 2017-05-30 | 2019-08-21 | Fmc Corp | Lactamas 3-sustituidas herbicidas |
| GB201901559D0 (en) | 2019-02-05 | 2019-03-27 | Syngenta Crop Protection Ag | Herbicidal compositions |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1309692A (en) * | 1970-02-13 | 1973-03-14 | Ucb Sa | N-substituted lactams |
| GB8412357D0 (en) * | 1984-05-15 | 1984-06-20 | Ucb Sa | Pharmaceutical composition |
| CA2392879C (en) * | 1999-12-01 | 2005-03-29 | Ucb, S.A. | A pyrrolidineacetamide derivative alone or in combination for treatment of cns disorders |
| GB0004297D0 (en) * | 2000-02-23 | 2000-04-12 | Ucb Sa | 2-oxo-1 pyrrolidine derivatives process for preparing them and their uses |
| WO2002067931A1 (en) * | 2001-02-23 | 2002-09-06 | Johns Hopkins University | Treatment of tics, tremors and related disorders |
-
2002
- 2002-10-07 DE DE60218193T patent/DE60218193T2/de not_active Expired - Lifetime
- 2002-10-07 CA CA002461961A patent/CA2461961A1/en not_active Abandoned
- 2002-10-07 US US10/489,660 patent/US20040242671A1/en not_active Abandoned
- 2002-10-07 PL PL02370529A patent/PL370529A1/pl not_active Application Discontinuation
- 2002-10-07 AU AU2002340971A patent/AU2002340971B2/en not_active Ceased
- 2002-10-07 AT AT02774687T patent/ATE353645T1/de not_active IP Right Cessation
- 2002-10-07 JP JP2003533931A patent/JP4351909B2/ja not_active Expired - Fee Related
- 2002-10-07 ES ES02774687T patent/ES2281545T3/es not_active Expired - Lifetime
- 2002-10-07 WO PCT/EP2002/011203 patent/WO2003030899A2/en not_active Ceased
- 2002-10-07 EP EP02774687A patent/EP1435943B1/en not_active Expired - Lifetime
- 2002-10-07 HU HU0401667A patent/HUP0401667A2/hu unknown
- 2002-10-07 MX MXPA04002714A patent/MXPA04002714A/es not_active Application Discontinuation
-
2007
- 2007-06-29 US US11/819,892 patent/US20080167366A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| MXPA04002714A (es) | 2004-07-05 |
| ATE353645T1 (de) | 2007-03-15 |
| JP4351909B2 (ja) | 2009-10-28 |
| US20040242671A1 (en) | 2004-12-02 |
| AU2002340971B2 (en) | 2007-04-26 |
| JP2005504834A (ja) | 2005-02-17 |
| HUP0401667A2 (hu) | 2004-12-28 |
| CA2461961A1 (en) | 2003-04-17 |
| US20080167366A1 (en) | 2008-07-10 |
| WO2003030899A3 (en) | 2004-01-08 |
| ES2281545T3 (es) | 2007-10-01 |
| DE60218193D1 (de) | 2007-03-29 |
| EP1435943B1 (en) | 2007-02-14 |
| EP1435943A2 (en) | 2004-07-14 |
| WO2003030899A2 (en) | 2003-04-17 |
| DE60218193T2 (de) | 2007-11-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2002225772A1 (en) | Therapeutic agents and methods of use thereof for treating an amyloidogenic disease | |
| DE60218193D1 (de) | Verwendung von 2-oxo-1-pyrrolidin-derivaten zur herstellung eines arzneimittels zur behandlung von dyskinesia | |
| CY1115484T1 (el) | Ενωσεις, συνθεσεις και μεθοδοι για την θεραπεια αμυλοειδικων ασθενειων και συνουκλεϊνοπαθειων, οπως νοσος alzheimer, διαβητης τυπου 2 και νοσος parkinson | |
| GEP20074208B (en) | Substituted amides active at the cannabinoid-1 receptor | |
| TW200501983A (en) | Uses of anti-insulin-like growth factor I receptor antibodies | |
| BG106251A (en) | Levodopa (carbidopa) entacapone pharmaceutical preparation | |
| IL189546A0 (en) | Therapy for the treatment of disease | |
| SG166125A1 (en) | New pyrimidine derivatives and their use in therapy as well as the use of pyrimidine derivatives in the manufacture of a medicament for prevention and/or treatment of alzheimeræs disease | |
| DE60032749D1 (de) | Stabilisierte pharmazeutische zusammensetzung enthaltend einen nichtsteroiden entzündungshemmenden wirkstoff und prostaglandin | |
| PL343771A1 (en) | N-substituted aminotetralins as ligands for the neuropeptide y y5 receptor useful in the treatment of obesity and other disorders | |
| IL158668A0 (en) | Deuterated 3-piperidinopropiophenone and medicaments containing said compounds | |
| ZA200209982B (en) | Transdermal therapeutic system for parkinson's disease inducing high plasma levels of rotogotine. | |
| IL161154A0 (en) | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 | |
| UA98462C2 (ru) | Способы лечения аутоиммунных заболеваний с использованием слитой молекулы taci-ig | |
| AU9551201A (en) | Combination of a transdermal therapeutic system and an oral and/or parenteral preparation containing dopamine agonists for the treatment of dopaminergic diseasestates | |
| GB2431346B (en) | A combination composition comprising paracetamol and ibuprofen | |
| SG158863A1 (en) | Intravenous formulations of pde-5 inhibitors | |
| DE60320579D1 (de) | Mucuna pruriens und extrakte daraus zur behandlung von neurologischen erkrankungen | |
| SG145717A1 (en) | Composition for releasing a weak base for an extended period of time | |
| GEP20043377B (en) | Pharmaceutical Complex | |
| SG163500A1 (en) | Composition and method for improved bioavailiability and enhanced brain delivery of 5,5-diphenyl barbituric acid | |
| GEP20053512B (en) | S-Methyl-Dihydro-Ziprasidone for Treatment of Psychiatric and Ocular Disorders. | |
| MY131159A (en) | New pharmaceutical compositions containing epinastine and pseudoephedrine | |
| EA200400691A1 (ru) | Получение чистых стереоизомеров трицикло[5,2,1,02,6]дец-9-ил-ксантогената и содержащие их лекарственные средства | |
| TW200501967A (en) | Nemorubicin for use in the preparation of a medicament for liver disease |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| REFS | Decisions on refusal to grant patents (taken after the publication of the particulars of the applications) |